{"id":"W2161512169","doi":"10.1177/1352458514557986","title":"Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Prothena; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; Teva Pharmaceutical Industries; Biogen; Sanofi","keywords":"Medicine; Dosing; Placebo; Regimen; Internal medicine; Multiple sclerosis; Randomized controlled trial; Gastroenterology; Surgery; Pathology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004483731,0.00106236,0.002410826,0.0003327387,0.0002666334,0.0006858818,0.0005084446,0.001155344,0.001749548],"category_scores_gemma":[0.001359359,0.0003153259,0.001848162,0.0003569162,0.0004501113,0.000746062,0.000559308,0.00160574,0.0003726954],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000450322,"about_ca_system_score_gemma":0.0007007218,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008060233,"about_ca_topic_score_gemma":0.001146876,"domain_scores_codex":[0.9991331,0.0004155079,0.00005373463,0.0001262317,0.0001359036,0.0001355612],"domain_scores_gemma":[0.9983563,0.0002268118,0.0005016936,0.000212408,0.0001616466,0.0005411957],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9215353,0.01317321,0.01065809,0.000355469,0.001632342,0.00008666157,0.00007285786,0.0009153771,0.007714032,0.00005340358,0.001010679,0.04279268],"study_design_scores_gemma":[0.402899,0.4749761,0.1114188,0.00008469875,0.002765448,0.0003235287,0.00004514006,0.0009641651,0.003462333,0.0001033075,0.002911463,0.0000459565],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927142,0.004963861,0.0002240352,0.0002051233,0.00006087118,0.0003242102,0.0007331205,0.00003569836,0.0007389427],"genre_scores_gemma":[0.9911959,0.002363212,0.000835439,0.0004395433,0.0002696894,0.0003601436,0.002816785,0.00001447773,0.001704755],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004483731,"threshold_uncertainty_score":0.02371252,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1245822529333655,"score_gpt":0.2962346911310162,"score_spread":0.1716524381976507,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}